CCND2 amplification is an independent adverse prognostic factor in IDH-mutant lower-grade astrocytoma. Richardson TE, Walker JM. Clin Neuropathol 2021;40:209-214.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Richardson TE, Walker JM. CCND2 amplification is an independent adverse prognostic factor in IDH-mutant lower-grade astrocytoma. Clin Neuropathol 2021;40:209-214.
PMID: 33560216